Page last updated: 2024-08-18

pyrroles and Cardiac Output, Low

pyrroles has been researched along with Cardiac Output, Low in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Braunwald, E; Cannon, CP; Jarolim, P; McCabe, CH; Morrow, DA; Ray, KK; Sabatine, MS; Scirica, BM; Shui, A	1
Carr, AN; Dorn, GW; Hahn, H; Hambleton, M; Hewett, TE; Kimball, TF; Klevitsky, R; Koch, WJ; Kuhn, MC; Molkentin, JD; Pleger, ST	1
Tall, AR; Wang, N; Yvan-Charvet, L	1

Reviews

1 review(s) available for pyrroles and Cardiac Output, Low

Article	Year
Intensive statin therapy and the risk of hospitalization for heart failure after an acute coronary syndrome in the PROVE IT-TIMI 22 study. Journal of the American College of Cardiology, 2006, Jun-06, Volume: 47, Issue:11 Topics: Acute Disease; Atorvastatin; Cardiac Output, Low; Coronary Disease; Heptanoic Acids; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Natriuretic Peptide, Brain; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Risk Assessment; Syndrome	2006

Article

Year

Intensive statin therapy and the risk of hospitalization for heart failure after an acute coronary syndrome in the PROVE IT-TIMI 22 study.

Journal of the American College of Cardiology, 2006, Jun-06, Volume: 47, Issue:11

Topics: Acute Disease; Atorvastatin; Cardiac Output, Low; Coronary Disease; Heptanoic Acids; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Natriuretic Peptide, Brain; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Risk Assessment; Syndrome

2006

Other Studies

2 other study(ies) available for pyrroles and Cardiac Output, Low

Article	Year
Pharmacological- and gene therapy-based inhibition of protein kinase Calpha/beta enhances cardiac contractility and attenuates heart failure. Circulation, 2006, Aug-08, Volume: 114, Issue:6 Topics: Animals; Calcium; Cardiac Output, Low; Cardiomyopathy, Dilated; DNA; Enzyme Activation; Female; Gene Expression Regulation; Genetic Therapy; Indoles; Male; Mice; Mice, Knockout; Myocardial Contraction; Myocardial Infarction; Myocardium; Protein Kinase C; Protein Kinase C beta; Protein Kinase C-alpha; Pyrroles; Rats; Rats, Sprague-Dawley; Signal Transduction	2006
The failure of torcetrapib: was it the molecule or the mechanism? Arteriosclerosis, thrombosis, and vascular biology, 2007, Volume: 27, Issue:2 Topics: Angina Pectoris; Animals; Anticholesteremic Agents; Atorvastatin; Cardiac Output, Low; Cardiovascular Diseases; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Drug Therapy, Combination; Heptanoic Acids; Humans; Mice; Myocardial Revascularization; Pyrroles; Quinolines; Rabbits; Treatment Failure	2007

Article

Year

Pharmacological- and gene therapy-based inhibition of protein kinase Calpha/beta enhances cardiac contractility and attenuates heart failure.

Circulation, 2006, Aug-08, Volume: 114, Issue:6

Topics: Animals; Calcium; Cardiac Output, Low; Cardiomyopathy, Dilated; DNA; Enzyme Activation; Female; Gene Expression Regulation; Genetic Therapy; Indoles; Male; Mice; Mice, Knockout; Myocardial Contraction; Myocardial Infarction; Myocardium; Protein Kinase C; Protein Kinase C beta; Protein Kinase C-alpha; Pyrroles; Rats; Rats, Sprague-Dawley; Signal Transduction

2006

The failure of torcetrapib: was it the molecule or the mechanism?

Arteriosclerosis, thrombosis, and vascular biology, 2007, Volume: 27, Issue:2

Topics: Angina Pectoris; Animals; Anticholesteremic Agents; Atorvastatin; Cardiac Output, Low; Cardiovascular Diseases; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Drug Therapy, Combination; Heptanoic Acids; Humans; Mice; Myocardial Revascularization; Pyrroles; Quinolines; Rabbits; Treatment Failure

2007